The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type

Extranodal natural killer/T cell lymphoma (ENKL) is a high invasive disease with poor prognosis. Since there is no consensus on standard chemotherapy, we developed an original chemotherapeutic DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen. We retrospectively analyzed 80 pati...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Zhang, Lei, Li, Sucai, Jia, Sisi, Nan, Feifei, Li, Zhaoming, Cao, Jingyu, Fan, Shanshan, Zhang, Chao, Su, Liping, Wang, Jinghua, Xue, Hongwei, Zhang, Mingzhi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5295438/
https://ncbi.nlm.nih.gov/pubmed/27517317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11135
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia